SARS CoV 2 Clinical Trials

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED
Z
Biomarkers for Post-COVID Conditions
Not yet recruiting
  • COVID-19
  • +3 more
    • (no location specified)
    2022-01-17
    Jan 17, 2022
    P
    Efficacy and Safety of Oral Lactobacillus Plantarum GUANKE (CGMCC NO.21720) in Enhancement of Antibody Level After SARS-CoV-2 Vaccination (Trial 2)
    Not yet recruiting
    • SARS-CoV-2
    • 1 week placebo(Week 1)
    • +5 more
    • Beijing, China
    • +1 more
    2022-01-12
    Jan 12, 2022
    P
    Efficacy and Safety of Oral Lactobacillus Plantarum GUANKE (CGMCC NO.21720) in Enhancement of Antibody Level After SARS-CoV-2 Vaccination (Trial 1)
    Not yet recruiting
    • SARS-CoV-2
    • Probiotics daily
    • Placebo daily
    • Beijing, China
    • +1 more
    2022-01-12
    Jan 12, 2022
    C
    A Study to Evaluate the Safety, Reactogenicity and Immunogenicity of Vaccine CVnCoV in Healthy Adults - 2021
    Completed
    • Severe Acute Respiratory Syndrome
    • +3 more
    • CVnCoV Vaccine
    • Placebo
    • Ghent, Belgium
    • +3 more
    2021-12-22
    Dec 22, 2021
    U
    Screening for COVID-19 and Monitoring of Serological Responses to SARS-CoV-2 in Healthcare Workers
    Active, not recruiting
    • SARS-CoV-2
    • Nasal swab
    • Serum testing
    • Greifswald, Germany
      Greifswald University Medicine
    2021-12-17
    Dec 17, 2021
    M
    A Study to Evaluate the Immunogenicity and Safety of mRNA-1283 COVID-19 Vaccine Boosters
    Recruiting
    • SARS-CoV-2
    • mRNA-1283
    • +2 more
    • Phoenix, Arizona
    • +12 more
    2022-01-06
    Jan 6, 2022
    S
    A Live Recombinant Newcastle Disease Virus-vectored COVID-19 Vaccine Phase 1 Study.
    Recruiting
    • SARS-CoV-2
    • Sodium Chloride
    • +4 more
    • New York, New York
      Icahn School of Medicine at Mount Sinai
    2022-01-04
    Jan 4, 2022
    M
    A Study to Evaluate the Safety, Reactogenicity, and Effectiveness of mRNA-1273 Vaccine in Adolescents 12 to <18 Years Old to Prevent COVID-19
    Active, not recruiting
    • SARS-CoV-2
    • mRNA-1273
    • Placebo
    • Banning, California
    • +24 more
    2021-12-16
    Dec 16, 2021
    G
    GLS-5310 Vaccine for the Prevention of SARS-CoV-2 (COVID-19)
    Recruiting
    • SARS-CoV-2
    • GLS-5310
    • Placebo
    • Seoul, Korea, Republic of
      Korea University Guro Hospital
    2022-01-05
    Jan 5, 2022
    A
    Phase II/III Study of AZD2816, for the Prevention of COVID-19 in Adults
    Active, not recruiting
    • COVID-19
    • SARS-CoV-2
    • AZD1222
    • AZD2816
    • Brasilia, Brazil
    • +34 more
    2022-01-05
    Jan 5, 2022
    M
    A Study to Evaluate Efficacy, Safety, and Immunogenicity of mRNA-1273 Vaccine in Adults Aged 18 Years and Older to Prevent COVID-19
    Active, not recruiting
    • SARS-CoV-2
    • mRNA-1273
    • Placebo
    • Birmingham, Alabama
    • +99 more
    2021-12-18
    Dec 18, 2021
    M
    A Study to Evaluate Safety and Immunogenicity of mRNA-1273 Vaccine to Prevent COVID-19 in Adult Organ Transplant Recipients and in Healthy Adult Participants
    Recruiting
    • SARS-CoV-2
    • mRNA-1273
    • Atlanta, Georgia
    • +1 more
    2021-12-18
    Dec 18, 2021
    M
    A Study to Evaluate Safety and Effectiveness of mRNA-1273 COVID-19 Vaccine in Healthy Children Between 6 Months of Age and Less Than 12 Years of Age
    Recruiting
    • SARS-CoV-2
    • mRNA-1273
    • Placebo
    • Birmingham, Alabama
    • +86 more
    2021-12-18
    Dec 18, 2021
    M
    Moderna COVID-19 Vaccine mRNA-1273 Observational Pregnancy Outcome Study
    Recruiting
    • SARS-CoV-2
      • Durham, North Carolina
        IQVIA Call Center for United States and Canada
      2021-12-18
      Dec 18, 2021
      M
      Post-Marketing Safety Study of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) mRNA-1273 COVID-19 Vaccine in the United States
      Recruiting
      • SARS-CoV-2
        • New York, New York
          Aetion Inc.
        2021-12-16
        Dec 16, 2021
        U
        Biomarkers for Dexamethasone Response in Sars-Cov-2 / COVID-19 Pneumonia - 2021
        Terminated
        • Pneumonia, Viral
        • SARS-Cov-2
          • Montpellier, France
          • +1 more
          2021-12-01
          Dec 1, 2021
          U
          Hydroxychloroquine for COVID-19 Post-exposure Prophylaxis (PEP) - 2020
          Completed
          Has Results
          • COVID-19
          • +3 more
          • Hydroxychloroquine Sulfate
          • Ascorbic Acid
          • Los Angeles, California
          • +7 more
          2021-12-14
          Dec 14, 2021
          K
          The Efficacy of Pre-procedural Mouth Rinses on COVID-19 Saliva Viral Load - 2021
          Completed
          • SARS-CoV-2
          • +4 more
          • Distilled Water
          • +4 more
          • Jeddah, Saudi Arabia
            Alhamra TETAMMAN clinic (PHC)
          2021-12-10
          Dec 10, 2021
          K
          Gut Microbiota, the Potential Key to Modulating Humoral Immunogenicity of New Platform COVID-19 Vaccines
          Recruiting
          • Microbiome
          • +4 more
          • This is observational study
          • Seoul, Korea, Republic of
            Koera University Guro Hospital
          2021-12-08
          Dec 8, 2021
          G
          Safety and Immunogenicity Study of GX-19N, a COVID-19 Preventive DNA Vaccine in Healthy Adults
          Active, not recruiting
          • SARS-CoV-2
          • Seoul, Korea, Republic of
          • +4 more
          2021-11-25
          Nov 25, 2021
          C
          A Study of Immune Responses to the Virus That Causes COVID-19
          Active, not recruiting
          • SARS-CoV-2
          • COVID-19
          • Sample collection
          • Birmingham, Alabama
          • +51 more
          2021-12-07
          Dec 7, 2021
          U
          Lactoferrin for Prevention of COVID-19 in Health Care Workers - 2021
          Terminated
          • SARS-CoV-2
          • Bovine Lactoferrin
          • Maltodextrin
          • Lima, Lim, Peru
          • +1 more
          2021-12-01
          Dec 1, 2021
          G
          Safety and Immunogenicity Study of GX-19, a COVID-19 Preventive DNA Vaccine in Healthy Adults
          Active, not recruiting
          • SARS-CoV-2
          • Seoul, Korea, Republic of
            Severance hospital
          2021-11-25
          Nov 25, 2021
          C
          A Dose-Confirmation Study to Evaluate the Safety, Reactogenicity and Immunogenicity of Vaccine CVnCoV in Healthy Adults for COVID-19
          Active, not recruiting
          • Coronavirus
          • +3 more
          • CVnCoV 6 μg
          • +4 more
          • Panama city, Panama
          • +1 more
          2021-12-06
          Dec 6, 2021
          W
          Sirolimus in COVID-19 Phase 1 - 2021
          Withdrawn
          • SARS-CoV-2
          • Covid-19
          • Sirolimus 1 MG/ML
          • Placebo
          • Philadelphia, Pennsylvania
            Thomas Jefferson University Hospital
          2021-12-02
          Dec 2, 2021